Background illustration for clinical trials search

Skin Cancer Clinical Trials

Browse 473 skin cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase2, Phase3, Recruiting

Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

for
Mucosal Melanoma of the Head and Neck
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 16+

Code: NCT04318717

Phase2, Recruiting

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

for
Metastatic Melanoma, BRAF Gene Mutation
Location: Easton PA, Lexington KY, Nashville TN
Sponsor: Rina Plattner

Sex: All

Age: 18+

Code: NCT04903119

Phase1, Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

for
Metastatic Malignant Solid Neoplasm, Metastatic Melanoma,
Location: Duarte CA, Los Angeles CA, Stanford CA
Sponsor: Anusha Kalbasi

Sex: All

Age: 18 - 70+

Code: NCT04119024

Phase1, Recruiting

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

for
Melanoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06365619

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase1, Phase2, Recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

for
Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer,
Location: Pittsburgh PA
Sponsor: Dan Zandberg

Sex: All

Age: 18+

Code: NCT04114136

Phase2, Recruiting

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

for
Melanoma, Melanoma Stage III, Melanoma Stage IV,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06199713

Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

for
Melanoma, Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, Richmond VA
Sponsor: IO Biotech

Sex: All

Age: 18+

Code: NCT05280314

Phase2, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Boston MA, Lake Success NY, Hackensack NJ,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

Naltrexone and Propranolol Combined With Immunotherapy

for
Advanced Melanoma
Location: New Brunswick NJ
Sponsor: Sarah Weiss

Sex: All

Age: 18+

Code: NCT05968690

Phase1, Recruiting

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

for
Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma,
Location: Harrison NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05607095

Phase1, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Providence RI, New Haven CT, Lebanon NH, Quebec,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

for
Mucosal Melanoma
Location: Harrison NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05384496

Phase2, Recruiting

MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

for
Melanoma
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05373823

Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

for
Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT00001823

Recruiting

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Austin TX, San Antonio TX, Scottsdale AZ
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT05094804

Phase1, Phase2, Recruiting

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

for
COVID-19 Infection, Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04474301

Recruiting

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

for
Advanced Melanoma
Location: Bethesda MD, Hialeah FL, Toronto, Pittsburgh PA,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT06697301

Phase2, Phase3, Recruiting

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

for
Melanoma
Location: New York NY, Charlottesville VA, Durham NC, Atlanta GA,
Sponsor: Craig L Slingluff, Jr

Sex: All

Age: 18+

Code: NCT05839912

Recruiting